Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2).
| Image |  |
|---|---|
| Description | scientific article published on 19 December 2016 |
| Author/s |
author: Mykola Stanislavchuk Pille Harrison |
| Publication date | December 19, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |